Blocking cytokines secreted by CAFs (such as IL-6, IL-8, IL-10 and TGF-β) combined with PD-1/PD-L1 can improve the anti-tumor immune response through increasing T cell infiltration and alleviating the role of PD-1 in inhibiting T cell activity (3). Here, TGFB1 is linked to neoplasm.